Qiming Venture Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 40
- Investments
- 893
- Portfolio
- 355
- Exits
- 186
Qiming Venture Partners General Information
Description
Founded in 2006, Qiming Venture Partners is a venture capital firm headquartered in Shanghai, China with additional offices in Beijing, Suzhou, Hong Kong, Seattle, Boston, and San Francisco Bay Area. The firm prefers to invest in companies operating in the technology, media and entertainment, telecommunications, and healthcare
Contact Information
Website
www.qimingvc.com
Year Founded
2006
Investor Status
Actively Seeking New Investments
Trade Association
China Venture Capital Association (CVC)
Primary Investor Type
Venture Capital
Primary Office
- Room 3906 Jinmao Tower
- 88 Century Boulevard
- Shanghai, 200121
- China
+86 021 0000 0000
Qiming Venture Partners Investments & Acquisitions (893)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| BUD ( Entertainment Software) | 23-May-2022 | Early Stage VC | 000.00 | Entertainment Software | Generating Revenue | |
| 00000 (00000 000) | 22-May-2022 | 00000 00000 | 000.00 | Entertainment Software | Generating Revenue | 0000 00 |
| 00000000 000 00000 | 22-May-2022 | 00000 00000 | Medical Supplies | Generating Revenue | ||
| 0000000 000000 | 08-May-2022 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 | 0000 00 |
| 00000000 | 05-May-2022 | 00000 00000 | Pharmaceuticals | Generating Revenue | ||
| 00000 0000000 0000 | 05-May-2022 | 00000 00000 | Biotechnology | Product Development | ||
| 000 00000000 | 29-Apr-2022 | 00000 00000 | Laboratory Services (Healthcare) | Startup | ||
| 000 000000000 | 20-Apr-2022 | 0000 00000 | 000.00 | General Purpose Semiconductors | Startup | |
| Houmo.AI | 19-Apr-2022 | Early Stage VC | Application Specific Semiconductors | Generating Revenue | ||
| OneChip | 19-Apr-2022 | Later Stage VC | 000.00 | Electronic Equipment and Instruments | Generating Revenue |
Qiming Venture Partners Exits (186)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| HilleVax | 29-Apr-2022 | IPO | 00000 |
| 00000 | 30-Mar-2022 | 000 | 00000 |
| 0000000 0000000000 | 07-Jan-2022 | 000 | 00000 |
| 00000000 0-000000 | 14-Dec-2021 | 000 | 00000 |
| 000000000 000000 | 10-Dec-2021 | 000 | 000.00 |
| 00000 | 15-Nov-2021 | 000 | 00000 |
| 000 000 000000 | 15-Nov-2021 | 000 | |
| 000000 00000000000 | 21-Oct-2021 | 000 | 00000 |
| Abbisko Therapeutics | 13-Oct-2021 | IPO | 00000 |
| Micropoint | 01-Oct-2021 | Secondary Transaction - Private |
Qiming Venture Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Qiming Venture Partners‘s full profile, request access.
Request a free trialQiming Venture Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialQiming Venture Partners Team (77)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Grace Lee | Partner, Group Chief Operating Officer & Chief Financial Officer | 0 | Hong Kong, Hong Kong | ||
| Nisa Bernice Leung | Managing Partner | 000 | 00 | 00 | Hong Kong, Hong Kong |
| Robert Headley | Partner | Shanghai, China | |||
| Amy Tang | Healthcare Venture Partner | 0 | Hong Kong, Hong Kong | ||
| Maykin Ho Ph.D | Venture Partner | 0 | Hong Kong, Hong Kong |
Qiming Venture Partners Co-Investors (751)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sequoia Capital China | 27 | 0 | 00 |
|
|
| IDG Capital | 00 | 0 | 00 |
|
|
| Lilly Asia Ventures | 00 | 0 | 0 |
|
|
| GGV Capital | 00 | 0 | 00 |
|
|
| Hillhouse Capital Group | 00 | 0 | 0 |
|
|